Clinical Trials - A Scorecard for Clinical Trial Investigations in 2020

Clinical Trials - A Scorecard for Clinical Trial Investigations in 2020

Summary

The purpose of this report is to provide insight into the clinical trial landscape for 2020, an analyses of the main features of these trials, and quarterly trends, where relevant.

This report provides an overview of global clinical trials with a start date between January 1, 2020 and December 31, 2020. Due to the COVID-19 pandemic, many of these trials have either been interrupted or disrupted.

Scope

- The clinical trials data used for these analyses were extracted from GlobalDatas Clinical Trials Database. The data included clinical trials with a start date between January 1, 2020 to December 31, 2020, which were captured in the database as of February 13, 2021.
- The trials were analyzed and segmented by phase, single versus multinational trials, geography, sponsor type (industry versus non-industry), therapy area, indication, top sponsors, molecule type, and top drug trials.
- Additional analyses were conducted for trials that were completed or terminated, as well as COVID-19 trials in all recruitment statuses. COVID-19 was the top indication for clinical trials at the time when the data were locked for analysis.

Reasons to Buy

- Understand the global clinical trial landscape in 2020
- The trends of completed clinical trials in 2020
- The trends of clinical trial terminations in 2020
- A closer look at COVID-19 clinical trials in 2020
- Understand the changes in 2020 and the impact for 2021

Executive Summary
Introduction
Report Scope
Methodology
Global Clinical Trial Landscape in 2020
Completed Trials in 2020
Clinical Trial Terminations in 2020
Spotlight on COVID-19 Clinical Trials for 2020
Key Findings
Appendix

List Of Tables

Table 1: Top Industry-Sponsored Innovator Drugs in Clinical Development by Primary Intervention for 2020
Table 2: Top Industry-Sponsored Biosimilar Drugs in Clinical Development by Primary Intervention for 2020
Table 3: Top Terminated Drugs in Clinical Development, by Clinical Trial Count

List Of Figures

Figures 1 & 2: Clinical Trials by Sponsor Type, Status and Initiation/Completion
Figures 3 & 4: Clinical Trials, by Phase and Sponsor Type
Figure 5: Single Country and Multinational Trials
Figure 6: Clinical Trials Regions, by Phase
Figure 7: Clinical Trials Regions, by Phase and Distribution
Figure 8: Planned Clinical Trials Country, by Phase
Figure 9: Clinical Trials Country, by Phase and Distribution
Figure 10: Clinical Trials Top Therapy Areas, by Phase
Figure 11: Clinical Trials Top Therapy Areas, by Phase and Distribution
Figure 12: Pivotal/Registration Clinical Trials Top Therapy Areas, by Phase
Figure 13: Clinical Trials Top Indications, by Phase
Figure 14: Clinical Trials Top Indications, by Phase and Distribution
Figure 15: Pivotal/Registration Clinical Trials Top Indications, by Phase
Figure 16: Clinical Trials Top Industry Sponsors, by Phase
Figure 17: Clinical Trials Top Non-Industry Sponsors, by Phase
Figure 18: Pivotal/Registration Clinical Trials Top Industry Sponsors, by Phase
Figure 19: Completed Trials Endpoint Status, by Sponsor Type
Figure 20 & 21: Completed Trials Endpoint Status, by Sponsor Type and Phase
Figure 22: Pivotal/Registration Industry Sponsored Trials Endpoint Status, by Phase
Figure 23: Completed Clinical Trials Top Sponsors, by Phase
Figure 24: Top Completed Drugs, by Clinical Trial Count
Figure 25 & 26: Terminated Trials, by Phase and Reason
Figure 27: Terminated Clinical Trials Top Therapy Areas, by Phase
Figure 28: Terminated Clinical Trials Top Indications, by Phase
Figure 29: Terminated Clinical Trials for Sponsors, by Phase
Figure 30: Clinical Trials for COVID-19, by Status and Sponsor Type
Figure 31: Clinical Trials for COVID-19, by Phase
Figure 32: Clinical Trials for COVID-19, by Top Industry Sponsors
Figure 33: Clinical Trials for COVID-19, by Top Non-Industry Sponsors
Figure 34 & 35: Clinical Trials for COVID-19, by Molecule Type and Phase
Figure 36 & 37: Reasons for Trial Disruptions

Fill The Form For Sample Request

Full Name*

Business Email *

E-mail

Country *

Select Country Albania Algeria Afghanistan Angola Argentina Armenia Aruba Australia Austria Azerbaijan Andorra Anguilla Bahrain Bangladesh Barbados Belarus Belgium Benin Bermuda Bhutan Bolivia Bosnia and Herzegovina Botswana Brazil Brunei Bulgaria Burkina Faso Burundi Bosnia Cambodia Cameroon Central African Republic Chad Chile China Colombia Comoros Congo (Brazzaville) Cook Islands Costa Rica Cote d Ivoire Croatia Cuba Cyprus Czech Republic Cayman Islands Denmark Djibouti Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Fiji Finland France Gabon Gambia Georgia Germany Ghana Gibraltar Greece Guam Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Honduras Hong Kong Hungary Herzegovina Iceland India Indonesia Iran Iraq Ireland Isle of Man Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Kuwait Korea Kyrgyzstan Laos Latvia Lebanon Lesotho Liberia Libya Lithuania Luxembourg Liechtenstein Macau Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Mauritania Mauritius Mexico Moldova Monaco Mongolia Montenegro Morocco Mozambique Myanmar Middle East & North Africa (MENA) Namibia Nauru Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria North Korea Norway Oman Pakistan Palau Palestinian Territories Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Puerto Rico Palestine Qatar Romania Russia Rwanda Samoa Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South Korea Spain Sri Lanka Saint Kitts and Nevis Saint Vincent and the Grenadines Sudan Suriname Swaziland Sweden Switzerland Syria Scotland San Marino Taiwan Tajikistan Tanzania Thailand Timor-Leste Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States of America Uruguay Uzbekistan Uraguay Vanuatu Venezuela Vietnam Virgin Islands Yemen Zambia Zimbabwe Canada Grenada Cape Verde Belize Curacao Republic of Srpska Antigua and Barbuda Saint Lucia Falkland Islands Faroe Islands Federated States of Micronesia Guadeloupe Martinique Montserrat Niue

Contact No *

Alternate No

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available